|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Danirixin>> Market Analysis Reports |
Market Analysis Reports of Danirixin |
|
C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2018 C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2018 SUMMARY C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High ... C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2018 C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2018 SUMMARY C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High ... Chronic Obstructive Pulmonary Disorder (COPD): KOL Insight [2018] ... ) BCT197 (Mereo Biopharma) Nemiralisib (GSK) Danirixin (GSK) RPL554 (Verona) KOLs interviewed ... COPD: KOL Insight ... ) BCT197 (Mereo Biopharma) Nemiralisib (GSK) Danirixin (GSK) RPL554 (Verona) KOLs interviewed ... COPD [2017] Are closed triple combos expected to change treatment dynamics? New treatment guidelines look set to change the way in which COPD is treated. New guidelines from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommend LABA/LAMAs as ... |